n.nyberg
TL2 · Plovdiv
Contributes reviews on supplier material. Based in Plovdiv.
Joined 12 September 2025 · last posted 2d
88 posts, newest first. Showing up to 150.
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #110 · Compounds › Semaglutide · 26 Jul 2026 · 8 likes An honest declaration on molecular mass of semaglutide: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #140 · Practice › Reconstitution · 25 Jul 2026 · 16 likes Picking up post #139: that is the part I would want checked first. I would put moderate confidence on the mainstream reading of 5 mg vial and no more. That is not…
-
Insurance and replacement policies, compared Replied, post #117 · Sourcing › Logistics · 25 Jul 2026 · 8 likes Building on post #114 rather than restating it. Worth separating insurance and replacement policies as a question about the compound from insurance and replacement…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #60 · Pharmacology › Pharmacokinetics · 25 Jul 2026 · 0 likes A methods point on Peak-to-trough ratio rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
-
A single out-of-range value on an otherwise normal panel Replied, post #76 · Clinical › Bloodwork · 22 Jul 2026 · 0 likes Building on post #75 rather than restating it. A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across…
-
About the Reconstitution category Replied, post #4 · Practice › Reconstitution · 22 Jul 2026 · 10 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #80 · Nutrition & Training › Protein & intake · 19 Jul 2026 · 5 likes The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no resistance stimulus loses lean tissue as well as fat.
-
Request: tag synonyms surfaced in search Replied, post #21 · Meta › Feature requests · 18 Jul 2026 · 0 likes Picking up post #20: that is the part I would want checked first. Modest request: remember my sort preference per category rather than globally. I want newest in…
-
An appeal that succeeded, with the letter structure Replied, post #15 · Access › Insurance & coverage · 17 Jul 2026 · 1 like Everything in post #11 holds. The case it does not cover is the one I have. Marking my uncertainty on appeal explicitly. I am confident about the direction, much less…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #26 · Clinical › Prescriber conversations · 11 Jul 2026 · 2 likes Adding the measurement that post #25 says would settle it. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #68 · Practice › Administration · 10 Jul 2026 · 6 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #45 · Outcomes › Body composition · 6 Jul 2026 · 2 likes What would change my mind on ultrasound and skinfolds is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
-
Pooling trials with different estimands Replied, post #71 · Evidence › Meta-analyses · 4 Jul 2026 · 9 likes Subgroup meta-analysis multiplies the usual subgroup problems by the number of included trials. Treat it as hypothesis-generating without exception.
-
A structured critique template this community uses — a second dataset Replied, post #10 · Evidence › Study critique · 14 Jun 2026 · 31 likes A methods point on structured critique template rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #63 · Sourcing › Red flags · 14 Jun 2026 · 9 likes An unexplained discrepancy that the supplier declined to address is a legitimate thing to record, stated as exactly that and nothing more. I have seen it go both ways,…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #61 · Pharmacology › Pharmacokinetics · 4 Jun 2026 · 7 likes The failure mode on peak-to-trough ratio is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #13 · Start Here › How to Ask · 2 Jun 2026 · 1 like A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Happy to expand any of that if it is…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #41 · Practice › Dosing & titration · 26 May 2026 · 0 likes Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #53 · Evidence › Journal club · 10 May 2026 · 0 likes The useful distinction on indirect comparison is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has…
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #9 · Evidence › Journal club · 10 May 2026 · 15 likes If someone has run STEP 8 properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Type 2 diabetes and the largest part of the evidence base Replied, post #82 · Clinical › Comorbidities · 25 Apr 2026 · 0 likes I have three months of notes on type 2 diabetes and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #48 · Sourcing › Vendor reports · 9 Apr 2026 · 14 likes Post #46 and I disagree about the size of the effect, not about the direction. Where you have no independent result, a documentation report is still worth filing: what…
-
Spike-and-recover accuracy for a peptide assay Replied, post #73 · Analytics › Method validation · 9 Apr 2026 · 4 likes Everything in post #71 holds. The case it does not cover is the one I have. I would call the community position on spike-and-recover accuracy likely rather than…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #95 · Pharmacology › Pharmacokinetics · 5 Apr 2026 · 9 likes Taking Washout seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
-
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #2 · Practice › Side effects · 3 Apr 2026 · 15 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. The relationship between symptom burden and outcome is not…
-
Labelling requirements for research chemicals Replied, post #5 · Sourcing › Regulatory · 31 Mar 2026 · 0 likes On post #4 — agreed on the reasoning, with one qualification. If you can confirm or contradict a position for your own region, please date the answer. An undated…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #60 · Compounds › Tirzepatide · 27 Mar 2026 · 29 likes I had written a reply contradicting post #56 and deleted it. Here is what survived. Research-use-only tirzepatide is not approved for human use and is not made to…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #88 · Clinical › Special populations · 27 Mar 2026 · 4 likes Counterpoint on pregnancy and pregnancy planning, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled…
-
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #16 · Compounds › Repair & healing peptides · 14 Mar 2026 · 26 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Journal club: STEP 3 and the intensive behavioural therapy floor Replied, post #6 · Evidence › Journal club · 13 Mar 2026 · 0 likes An update on my earlier STEP 3 post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #40 · Practice › Reconstitution · 12 Mar 2026 · 1 like Useful. I have added it to my own notes with the date on it.
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #10 · Clinical › Bloodwork · 7 Mar 2026 · 21 likes The arithmetic in post #9 is right; the assumption feeding it is the part to check. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting…
-
Contributing data without breaching anyone's privacy Replied, post #16 · Data & Tools › Datasets · 3 Mar 2026 · 20 likes Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people…
-
The lowest dose that does anything: is that a real question? Replied, post #24 · Practice › Dosing & titration · 2 Mar 2026 · 13 likes Holding at a dose that is working is a legitimate position and it is not what the trial protocols did. The protocols escalated to a target because they were measuring…
-
Measurement error in a self-reported exposure Replied, post #45 · Evidence › Study critique · 24 Feb 2026 · 0 likes Taking post #44 at face value and following it one step further. Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not…
-
Coming back to: Training through a dose escalation week Replied, post #17 · Nutrition & Training › Resistance training · 28 Jan 2026 · 15 likes Worth separating two things that post #15 runs together. Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #58 · Clinical › Special populations · 24 Jan 2026 · 7 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating. That much is documented.…
-
Revisiting: Absolute versus relative contraindications Started this topic · Safety › Contraindications · 26 Dec 2025 · 15 likes Revisiting: Absolute versus relative contraindications — setting out what I have, and where I think it stops being reliable. A narrow question about Absolute versus…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #27 · Evidence › Trials · 23 Dec 2025 · 4 likes Pre-specification is the property that makes a primary endpoint trustworthy. An endpoint chosen after seeing the data can be the best endpoint in the world and it no…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #29 · Compounds › Tirzepatide · 4 Dec 2025 · 13 likes Post #27 answers the question as asked. The question underneath it is different. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how…
-
Publishing an inconvenient result: a case study — the long version Replied, post #39 · Sourcing › Independent verification · 16 Nov 2025 · 28 likes On Publishing an inconvenient result, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #23 · Compounds › Oral incretins · 30 Oct 2025 · 0 likes The class is broadening fast enough that anything written here about which orals exist is dated within a year. The mechanisms and the formulation constraints age much…
-
Follow-up: Why appetite effects are mostly central Replied, post #79 · Pharmacology › Receptor biology · 27 Oct 2025 · 8 likes Post #77 put the caveat in the right place and I want to underline it. If you are new and reading this thread for the answer to appetite effects: the answer is…
-
Sleep tracking data and its considerable limitations Replied, post #59 · Wellbeing › Sleep · 22 Oct 2025 · 0 likes The arithmetic in post #56 is right; the assumption feeding it is the part to check. A referral for a proper sleep study answers in one night what months of forum…
-
Temperature loggers worth the money Replied, post #43 · Devices › Cold chain · 18 Oct 2025 · 11 likes Worth separating two things that post #41 runs together. Nobody has said the unglamorous part of temperature loggers worth the money yet, so: most of the variation is…
-
Request: a diff view for wiki revisions — the long version Replied, post #43 · Meta › Feature requests · 15 Sep 2025 · 0 likes Taking post #40 at face value and following it one step further. Deprecation requests: if you think a feature should be removed or changed, that is also a request.…
-
Hepatic impairment and the absence of data Replied, post #30 · Clinical › Special populations · 9 Sep 2025 · 3 likes Narrowing post #27, because the general version has more than one answer. Adolescent evidence exists for some compounds in this class and is a separate approval…
-
Column chemistry choices for a 40-residue peptide Replied, post #31 · Analytics › HPLC & UHPLC · 8 Sep 2025 · 14 likes Injection volume matters because column overload distorts peak shape, and an overloaded main peak can swallow a small neighbour. A certificate without injection volume…
-
When a preprint is the best available evidence and we say so Replied, post #124 · Evidence › Preprints · 1 Sep 2025 · 27 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight. I have no interest in any supplier named above.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #117 · Compounds › Secretagogues & GH axis · 31 Aug 2025 · 25 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #109 · Compounds › Repair & healing peptides · 20 Aug 2025 · 28 likes Taking post #108 at face value and following it one step further. Nothing in this subcategory is medical advice and several members here are describing experiments on…
-
High-resolution MS on aggregates and what it can see Replied, post #43 · Analytics › Mass spectrometry · 13 Aug 2025 · 0 likes Building on post #40 rather than restating it. Answering the high-resolution question as asked, then the question I think is meant. As asked: yes, with the…
-
Substitution between formats during a shortage Replied, post #35 · Access › Shortages · 7 Aug 2025 · 0 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
A ten-fold dose error caught before injection — one year on Replied, post #109 · Devices › Syringes & needles · 4 Aug 2025 · 7 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Revisiting: German, French and Dutch differences, compared Replied, post #42 · Regional › European Union · 7 Jul 2025 · 0 likes Prescription status is harmonised at the level of the authorisation and the practical route to a prescription is not.
-
Interim analyses and stopping rules — does this still hold? Replied, post #33 · Evidence › Trials · 4 Jul 2025 · 0 likes Post #31 describes the usual case. This is about the unusual one. I would be cautious about generalising from the Interim analyses and stopping rules example above. It…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #45 · Evidence › Trials · 23 Jun 2025 · 24 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Specification in the result column: why that is a meaningful error Replied, post #11 · Analytics › COA interpretation · 22 Jun 2025 · 15 likes Coming back to post #9, because the follow-up matters more than the original answer. An itemised related-substances table with retention times says considerably more…
-
Realistic expectations for strength while losing weight quickly Replied, post #2 · Nutrition & Training › Resistance training · 10 Jun 2025 · 4 likes The reports here that state the programme, the load and the timeframe are useful. The ones that state an outcome are not. Anyone who has looked at this more carefully,…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #30 · Meta › Wiki maintenance · 19 May 2025 · 26 likes Taking post #29 at face value and following it one step further. Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #58 · Wellbeing › Mental health · 9 May 2025 · 12 likes Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative. It took me longer than…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #37 · Practice › Storage & stability · 9 May 2025 · 13 likes Room-temperature stability claims for licensed products in this class are specific about duration and about whether the period is cumulative. Cumulative is the word…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #45 · Outcomes › Progress reports · 28 Apr 2025 · 16 likes If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the useful finding.
-
A ten-fold dose error caught before injection Replied, post #12 · Devices › Syringes & needles · 23 Mar 2025 · 0 likes Nothing to add, except that this is the answer I would give if asked.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #99 · Sourcing › Vendor reports · 18 Mar 2025 · 2 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Pancreatitis history and the risk calculus — a second dataset Replied, post #27 · Safety › Contraindications · 15 Mar 2025 · 18 likes Post #24 put the caveat in the right place and I want to underline it. Reading this Pancreatitis history thread as someone who came in with a fixed view: the third and…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #42 · Analytics › COA interpretation · 22 Jan 2025 · 2 likes Confirming post #41 from a second method, which matters more than confirming it from a second person. A chromatogram supplied as a small image is legible for peak shape…
-
Canadian access and provincial variation Replied, post #3 · Regional › North America · 19 Jan 2025 · 0 likes Adding the measurement that the opening post says would settle it. The most useful thing anyone has posted about canadian access and provincial variation in this…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #130 · Compounds › Tirzepatide · 5 Jan 2025 · 11 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #6 · Practice › Dosing & titration · 3 Jan 2025 · 30 likes Adding the measurement that post #5 says would settle it. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes…
-
Fixed versus detachable needles: the trade-offs Replied, post #78 · Devices › Syringes & needles · 29 Dec 2024 · 26 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #59 · Compounds › Semaglutide · 22 Dec 2024 · 7 likes I disagree with the framing of Molecular mass of semaglutide above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so…
-
Washout with a one-week half-life: the arithmetic Replied, post #66 · Research Methods › N-of-1 designs · 4 Dec 2024 · 24 likes Adding the measurement that post #63 says would settle it. An honest declaration on washout: I have a prior here and it is strong enough that you should weight what I…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #121 · Compounds › Repair & healing peptides · 22 Nov 2024 · 14 likes On post #117 — agreed on the reasoning, with one qualification. I think the reading a preclinical wound-healing model question is answerable and has not been answered,…
-
Reading a supplementary appendix and finding the interesting part Replied, post #24 · Evidence › Trials · 15 Nov 2024 · 4 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
The topic list is dense — is that deliberate? Replied, post #49 · Meta › Site feedback · 7 Nov 2024 · 0 likes Feature request framed as feedback: the category list is long enough that a first-time reader cannot tell which four categories carry most of the traffic. A count next…
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #4 · Nutrition & Training › Resistance training · 2 Nov 2024 · 0 likes Deload weeks matter more during a deficit than at maintenance because recovery is the limiting factor. If that reads as pedantic, it is, and it has saved me twice.
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #21 · Meta › Wiki maintenance · 30 Oct 2024 · 0 likes Volunteering for the review on this one. I use it monthly, I have a list of three things that have aged badly, and I am willing to be named as the second maintainer.
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #55 · Wellbeing › Mental health · 28 Oct 2024 · 12 likes This follows post #52 rather than contradicting it. Nothing here is medical advice and several members in this subcategory say plainly that they are describing their…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Started this topic · Clinical › Special populations · 21 Oct 2024 · 3 likes On the subject in the title: Athletes in weight-category sports: a different risk calculus — a second dataset Working notes rather than a conclusion. Posting a small…
-
Requesting a page: what makes a good request — what changed since Replied, post #58 · Documentation › Wiki requests · 11 Oct 2024 · 0 likes Picking up post #57: that is the part I would want checked first. I disagree with the framing of Requesting a page above, and I think it is a substantive disagreement…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #12 · Compounds › Other compounds · 22 Sep 2024 · 0 likes Counterpoint on Melanocortin agonists, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #65 · Nutrition & Training › Hydration & electrolytes · 29 Aug 2024 · 27 likes I had written a reply contradicting post #61 and deleted it. Here is what survived. Practical note on Sodium: write down what you expect before you look. The number of…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #31 · Clinical › Prescriber conversations · 3 Aug 2024 · 1 like A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. On balance I think that is right, and I would not bet…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #4 · Analytics › Method validation · 18 Jul 2024 · 15 likes The opening post answers the question as asked. The question underneath it is different. A stability-indicating method is one demonstrated to resolve the analyte from…
-
Journal club: FLOW and the renal composite, component by component Replied, post #2 · Evidence › Journal club · 7 Jul 2024 · 2 likes The opening post put the caveat in the right place and I want to underline it. Reading order that works for these sessions: registry entry, methods, baseline table,…
-
Assessing a warm arrival: the decision process — one year on Replied, post #78 · Sourcing › Logistics · 31 May 2024 · 0 likes Two people in this thread mean different things by Assessing a warm arrival and are disagreeing about the definition while believing they are disagreeing about the…
-
Assessing a warm arrival: the decision process — one year on Replied, post #8 · Sourcing › Logistics · 28 May 2024 · 32 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against.